Latest News

June 14, 2012
A new approach to drug design, pioneered by a group of researchers at UCSF and Mt. Sinai, New York, promises to help identify future drugs to fight cancer and other diseases that will be more effective and have fewer side effects.
June 11, 2012
The single thing that a woman can do to lower her risk of breast cancer is to avoid unnecessary medical imaging, says Rebecca Smith-Bindman, MD, a professor of radiology and biomedical imaging, epidemiology and biostatistics at UCSF, who contributed to a new Institute of Medicine report.
May 23, 2012
Construction of UCSF Medical Center at Mission Bay is well underway, with the building’s exterior panels, glass, and interior studs being installed.
May 18, 2012
To celebrate nearly a quarter-century of advances in hematology and transplantation, UCSF is holding a reunion of patients from the UCSF Medical Center who have undergone bone marrow transplants.
May 02, 2012
A pioneering approach to imaging breast cancer in mice has revealed new clues about why the human immune system often fails to attack tumors and keep cancer in check. This observation, by scientists at the University of California, San Francisco (UCSF), may help to reveal new approaches to cancer immunotherapy.
May 01, 2012
In a study of patients 65 and older with non-small-cell lung cancer (NSCLC), younger patients were more likely to receive treatment than older patients, regardless of overall health and prognosis.
April 23, 2012
Ten years ago, a landmark clinical trial in Canada demonstrated the unequivocal effectiveness of brain surgeries for treating uncontrolled epilepsy, but since then the procedure has not been widely adopted — in fact, it is dramatically underutilized according to a new UCSF study.
April 19, 2012
In honor of National Skin Cancer Awareness Month, the UCSF Department of Dermatology is offering free skin cancer screenings. The event is co-sponsored by Assemblyman Tom Ammiano, and San Francisco Supervisor Christina Olague.
April 17, 2012
A new brain cancer vaccine tailored to individual patients by using material from their own tumors has proven effective in a multicenter phase 2 clinical trial at extending their lives by several months or longer. The patients suffered from recurrent glioblastoma multiform — which kills thousands of Americans every year.
April 02, 2012
Frank McCormick, director of the Helen Diller Family Comprehensive Cancer Center at UCSF and new president of the 35,000-member American Association of Cancer Research, discusses the state of cancer research.

Pages